Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - men's health
Novel AKR1C3 inhibitors in cancer
Inhibitors and tools to block the local formation of steroid hormones in hormone-dependent malignancies of the prostate, breast and endometrium Technology Overview: Standard treatment of care for hormone-dependent tumors utilizes hormone ablative therapies. These agents non-discriminately block the action of estrogens and androgens and have untoward...
Therapeutics & Vaccines
© 2020. All Rights Reserved. Powered by